MedTrace Logo

Specific Clinical Experience Investigation for Long-term Use of Bydureon.

NCT01940770 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1137

Last updated 2020-07-20

No results posted yet for this study

Summary

To confirm the safety and efficacy of Bydureon in long-term use in Japanese patients with type 2 diabetes mellitus under actual drug use.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Shigeru Yoshida, MD · Quality & Safety Compliance Office

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-18
Primary Completion
2019-11-29
Completion
2019-11-29

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01940770 on ClinicalTrials.gov